|
|
|
| Coverage of enterovirus 71 vaccine among children born between 2018 and 2021 in Ningbo City |
| WANG Zhaya1, YE Lixia2, WU Feng3
|
1. Wenjiao Street Community Health Service Center, Jiangbei District, Ningbo, Zhejiang 315000, China;
2. Ningbo Center for Disease Control and Prevention, Ningbo, Zhejiang 315010, China;
3. Jiangbei District Center for Disease Control and Prevention, Ningbo, Zhejiang 315000, China |
|
|
|
|
Abstract Objective To investigate the coverage of enterovirus 71 (EV71) vaccine among children born between 2018 and 2021 in Ningbo City, Zhejiang Province, so as to provide insights into formulating EV71 vaccination strategy. Methods Data pertaining to demography and EV71 vaccination among children born between 2018 and 2021 in Ningbo City were obtained from the Zhejiang Immunization Information Management System, and the coverage of vaccination, full-dose vaccination and timely vaccination of EV71 vaccine were analyzed. Results Totally 416 176 children were born between 2018 and 2021, including 216 977 boys (52.14%) and 199 199 girls (47.86%). The coverage rates of vaccination, full-dose vaccination and timely vaccination was 61.50%, 58.70% and 32.53%, respectively. The coverage rates of vaccination, full-dose vaccination and timely vaccination among local children (71.43%, 70.04% and 40.24%) were higher than those among migrant children (54.05%, 50.18% and 26.73%; P<0.05). The coverage rates of vaccination, full-dose vaccination and timely vaccination among urban children (67.72%, 65.06% and 40.37%) were higher than those among rural children (54.11%, 51.14% and 23.21%; P<0.05). The coverage rates of vaccination were 54.98%, 61.24%, 65.10% and 66.72%, the coverage rates of full-dose vaccination were 52.16%, 58.72%, 62.44% and 63.39%, and the coverage rates of timely vaccination were 22.47%, 25.86%, 39.14% and 48.03% by the born year from 2018 to 2021, all showing increasing trends year by year (P<0.05). Conclusions The coverage of vaccination, full-dose vaccination and timely vaccination of EV71 vaccine appears a tendency towards a rise among the 2018-2021 birth cohorts in Ningbo City, while the coverage of timely vaccination need to be improved. Health education for EV71 vaccination should be enhanced for rural and migrant children.
|
|
Received: 10 July 2023
Revised: 29 August 2023
Published: 10 October 2023
|
|
|
|
|
|
[1] 中国疾病预防控制中心.肠道病毒71型灭活疫苗使用技术指南[EB/OL].[2023-08-29].https://www.chinacdc.cn/nip/ywdt/zcyj/zcjswj/202112/W020211206570536774575.pdf.
[2] 蒋卓婧,葛小萍,陈金堃,等.绍兴市手足口病病毒型别检测结果分析[J].预防医学,2022,34(5):507-510.
[3] YI E J,SHIN Y J,KIM J H,et al.Enterovirus 71 infection and vaccines[J].Clin Exp Vaccine Res,2017,6(1):4-14.
[4] MAO Q Y,WANG Y,BIAN L,et al.EV71 vaccine,a new tool to control outbreaks of hand,foot and mouth disease(HFMD)[J].Expert Rev Vaccines,2016,15(5):599-606.
[5] HU Y M,WANG X,WANG J Z,et al.Immunogenicity,safety,and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months[J].Clin Vaccine Immunol,2013,20(12):1805-1811.
[6] ZHU F,XU W,XIA J,et al.Efficacy,safety,and immunogenicity of an enterovirus 71 vaccine in China[J].N Engl J Med,2014,370(9):818-828.
[7] ZHU F C,MENG F Y,LI J X,et al.Efficacy,safety,and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China:a multicentre,randomised,double-blind,placebo-controlled,phase 3 trial[J].Lancet,2013,381(9882):2024-2032.
[8] 王凌虹,叶莉霞,顾永权,等.余姚市2012—2018年出生儿童肠道病毒71型疫苗接种分析[J].预防医学,2020,32(9):911-913,916.
[9] 潘伟毅,赵志远,陈俊磊.2017—2018年福建省0~5岁儿童出生队列肠道病毒71型疫苗接种率分析[J].中国生物制品学杂志,2020,33(3):293-296.
[10] 于静,汤奋扬,汪志国,等.江苏省2013—2020年出生队列儿童肠道病毒71型疫苗接种率[J].中国疫苗和免疫,2021,27(5):566-569.
[11] 贾斯月,李靖欣,朱凤才.基于EV71疫苗接种的江苏省手足口病动力学模型研究[J].中华疾病控制杂志,2019,23(3):253-258.
[12] 刘艳,杜渐,王骏,等.杭州市儿童肠道病毒71型灭活疫苗接种特征分析[J].国际流行病学传染病学,2020,47(1):38-41.
[13] 胡瑜超,于伟,鲍伟娜,等.柯桥区1~7岁儿童第二类疫苗接种情况分析[J].预防医学,2019,31(9):927-929.
[14] 刘向东,顾新蕊,冀天娇,等.2013—2015年中国重症手足口病的流行病学特征和病原构成[J].病毒学报,2018,34(4):477-482.
[15] 王丹,李法锦,姚光海,等.贵州省2009—2016年手足口病流行病学特征研究[J].中国疫苗和免疫,2017,23(4):450-454. |
|
|
|
